Diphtheria Antitoxin

Indications

• Diphtheria prevention through vaccination
• Management of diphtheria infections
• Treatment of complications arising from diphtheria toxin

Dosage

Children: Refer to established guidelines for the management of diphtheria in children. Treatment typically includes administration of diphtheria antitoxin and antibiotics.

Adults: Refer to established guidelines for the management of diphtheria. Treatment typically includes administration of diphtheria antitoxin and antibiotics.

Mechanism of action

Corynebacterium diphtheriae produces diphtheria toxin, which is a potent exotoxin that inhibits protein synthesis in host cells. The toxin binds to the heparin-binding epidermal growth factor (HB-EGF) receptor on cell membranes, facilitating its entry into cells. Once inside, it catalyzes the ADP-ribosylation of elongation factor-2 (EF-2), halting protein synthesis and leading to cell death.

Pharmacodynamics

The toxicity of diphtheria is primarily due to the action of its exotoxin. The severity of the disease is correlated with the amount of toxin produced, which can lead to local tissue necrosis in the throat, systemic effects such as myocarditis and neuropathy, and can be fatal if untreated. The immune response to the toxin plays a crucial role in recovery, as patients who have been previously vaccinated may exhibit milder disease due to pre-existing immunity.

Pharmacokinetics

The pharmacokinetics of diphtheria toxin involve its release into the bloodstream after local infections in the throat. The toxin can disseminate to various tissues, including the heart and nervous system, leading to systemic manifestations. The half-life of the toxin is not well established, but it is rapidly cleared from circulation following the development of antibodies in the host, which neutralize the toxin's effects.

Adverse effects

• Local reactions at the injection site
• Fever
• Fatigue
• Allergic reactions
• Anaphylaxis (rare)

Precautions

• History of severe allergic reactions to diphtheria toxoid or any component of the vaccine
• Use with caution in individuals with immunocompromised conditions

Pregnancy

Diphtheria vaccination is generally considered safe during pregnancy and is recommended to protect both the mother and fetus from potential exposure.

Breast-feeding

Diphtheria vaccination is safe during breastfeeding and is recommended as it helps to protect the infant.

Storage

Store in a refrigerator at 2-8 degrees Celsius. Do not freeze.

Formulations

• Diphtheria toxoid vaccine (inactivated)
• Diphtheria-tetanus-pertussis (DTP) combination vaccine

Indications

• Diphtheria prophylaxis
• Tetanus prophylaxis
• Pertussis prophylaxis (when combined with other vaccines)

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations for pediatric immunization with toxoids.

Adults: Refer to specific guidelines for each toxoid vaccine, as dosing may vary based on the type of vaccine and individual patient factors.

Mechanism of action

Toxoids work by stimulating the immune system to produce antibodies against the toxin without causing disease. When administered, the immune system recognizes the toxoid as a foreign substance and generates a specific immune response. This includes the production of immunoglobulin G (IgG) antibodies that can neutralize the active toxin if the individual is exposed to the bacteria in the future.

Pharmacodynamics

The pharmacodynamics of toxoids involve the activation of the adaptive immune response. After vaccination, dendritic cells present the antigen to T cells, which then help B cells differentiate into plasma cells that produce specific antibodies. The presence of these antibodies provides immunity against the toxin by neutralizing its effects, thereby preventing the disease associated with the original bacterial toxin.

Pharmacokinetics

Toxoids are typically administered via intramuscular or subcutaneous injection. Following administration, they are gradually taken up by antigen-presenting cells, which then process and present the toxoid to T cells. The immunogenic response can develop over several weeks. The duration of immunity can vary, necessitating booster doses to maintain adequate antibody levels over time.

Adverse effects

• Local reactions at the injection site, such as pain, swelling, or redness.
• Fever.
• Fatigue.
• Headache.
• Allergic reactions in rare cases.

Precautions

• Use with caution in individuals with a history of severe allergic reactions to a vaccine component.
• Monitor patients for allergic reactions post-vaccination.

Pregnancy

Toxoids are generally considered safe during pregnancy; however, consultation with a healthcare provider is recommended.

Breast-feeding

Toxoids are considered safe for use during breastfeeding.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Diphtheria toxoid
• Tetanus toxoid
• Pertussis toxoid